Alam Kamran

Alam Kamran is listed in filings as CHIEF FINANCIAL OFFICER at Taysha Gene Therapies, Inc.. This profile follows SEC Form 4 activity through Jan 27, 2026, including sale activity. Recent filings connect the profile to Taysha Gene Therapies, Inc. (TSHA). The current snapshot covers public activity from Jan 14, 2026 to Jan 27, 2026. Reported amounts are shown as $1.1M to $109.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.